The advantage of women in cancer survival: An analysis of EUROCARE-4 data

A Micheli, R Ciampichini, W Oberaigner, L Ciccolallo, Esther Vries, I Izarzugaza, P Zambon, G Gatta, R De Angelis

Research output: Contribution to journalArticleAcademicpeer-review

204 Citations (Scopus)

Abstract

We analysed 1.6 million population-based EUROCARE-4 cancer cases (26 cancer sites, excluding sex-specific sites, and breast) from 23 countries to investigate the role of sex in cancer survival according to age at diagnosis, site, and European region. For 15 sites (salivary glands, head and neck, oesophagus, stomach, colon and rectum, pancreas, lung, pleura, bone, melanoma of skin, kidney, brain, thyroid, Hodgkin disease and non-Hodgkin's lymphoma) age- and region-adjusted relative survival was significantly higher in women than men. By multivariable analysis, women had significantly lower relative excess risk (RER) of death for the sites listed above plus multiple myeloma. Women significantly had higher RER of death for biliary tract, bladder and leukaemia. For all cancers combined women had a significant 5% lower RER of death. Age at diagnosis was the main determinant of the women's advantage, which, however, decreased with increasing age, becoming negligible in the elderly, suggesting that sex hormone patterns may have a role in women's superior ability to cope with cancer. (C) 2008 Elsevier Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)1017-1027
Number of pages11
JournalEuropean Journal of Cancer
Volume45
Issue number6
DOIs
Publication statusPublished - 2009

Cite this